Aptose Reports Results for the First Quarter 2023
<!-- Name:DistributionId Value:8834370 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Tuspetinib
Aptose Initiates Dosing of Tuspetinib in APTIVATE Expansion Trial in Patients with…
<!-- Name:DistributionId Value:8738171 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Aptose Announces Updated Clinical Responses, Breadth of Activity, and Safety Across…
This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients.…